Help us: Donate
Follow us on:
×

Menu

Back

Month: August 2020

Image of someone editing DNA
A gene therapy treatment can ameliorate the loss of motor function and muscle strength in old mice, offering elderly people hope for continuing their active lives. DOK7 is crucial for muscle function Declining motor function is common with aging and can significantly reduce the quality of life. This decline occurs at least in part due...
virtual conference thumbnail
Last week, on Thursday and Friday, I attended a conference. No, it wasn't in a bustling hot conference center, with thousands of other people much closer than 6 feet from me talking about tech and disrupting various industries. Instead, I was sitting at home with my computer on my desk, drinking a hot cup of...
Image of knee inflammation caused by osteoarthritis
A collective of scientists has shown that osteoarthritis can be alleviated by guiding skeletal stem cells towards differentiation into chondrocytes, which are responsible for producing healthy cartilage [1]. Osteoarthritis (OA) is a classic example of an age-related disease. While almost non-existent in younger people, it affects as much as half of the over-65 population worldwide....
A new review takes a look at the association between the decline of the immune system and the development and course of age-related diseases. Our immune system is the ultimate defense against invading pathogens and unwanted waste, and its efficient operation is critical to the healthy function of every tissue in the body. We have...
Image of scissors cutting DNA to represent gene editing with CRISPR
The body can be home to many latent viruses, which can lie dormant for years only to be activated much later under certain conditions. Now, researchers may have the solution to one such persistent virus: herpes simplex virus 1, which is commonly known as oral herpes. Latent viruses put strain on the immune system A...
Unity biotechnology logo
While we enjoy reporting positive news, we do occasionally have to report bad news, and today is one of those days. There has been some disappointing news from UNITY Biotechnology with the release of its Phase 2 senolytic trial of its candidate drug UBX0101. SOUTH SAN FRANCISCO, Calif., Aug. 17, 2020 (GLOBE NEWSWIRE) -- UNITY...